Check-Cap Ltd. Stock

Equities

CHEK

IL0011336851

Biotechnology & Medical Research

Delayed Nasdaq 10:01:46 2024-05-20 am EDT 5-day change 1st Jan Change
2.16 USD -1.14% Intraday chart for Check-Cap Ltd. -0.92% +3.85%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Exceptional extension!
Take advantage of the offer
* See conditions on site
Sales 2022 - Sales 2023 - Capitalization 12.17M
Net income 2022 -19M Net income 2023 -17M EV / Sales 2022 -
Net cash position 2022 40.74M Net cash position 2023 24.76M EV / Sales 2023 -
P/E ratio 2022
-0.65 x
P/E ratio 2023
-0.69 x
Employees 85
Yield 2022 *
-
Yield 2023
-
Free-Float 74.84%
More Fundamentals * Assessed data
Dynamic Chart
1 day-1.14%
1 week-0.92%
Current month-2.92%
1 month-4.42%
3 months+1.89%
6 months-37.57%
Current year+3.85%
More quotes
1 week
2.05
Extreme 2.052
2.27
1 month
2.00
Extreme 2
2.31
Current year
1.78
Extreme 1.78
3.45
1 year
1.41
Extreme 1.41
4.63
3 years
1.22
Extreme 1.22
38.18
5 years
1.22
Extreme 1.22
89.80
10 years
1.22
Extreme 1.22
1 427.98
More quotes
Managers TitleAgeSince
Chief Executive Officer 57 Mar. 16
Founder 63 04-12-31
Director of Finance/CFO 54 Mar. 05
Members of the board TitleAgeSince
Founder 63 04-12-31
More insiders
Date Price Change Volume
24-05-20 2.16 -1.14% 1 353
24-05-17 2.185 -2.35% 14,010
24-05-16 2.238 +4.56% 13,593
24-05-15 2.14 -2.28% 6,973
24-05-14 2.19 +0.46% 13,804

Delayed Quote Nasdaq, May 20, 2024 at 10:01 am EDT

More quotes
Check Cap Ltd is an Israel-based clinical-stage medical diagnostics company. Check Cap Ltd develops C-Scan, patient-friendly preparation-free test designed to detect polyps before they may transform into cancer to enable early intervention and cancer prevention. It's capsule-based screening technology aims to increase screening adherence worldwide. The system utilizes ultra-low-dose X- rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities. C-Scan is non-invasive capsule that is propelled through the gastrointestinal tract by natural motility. C-Scan is comprised of three main components: C-Scan Cap, an ingestible X-ray scanning capsule; C-Scan Track, three miniaturized patches worn on the patient’s back for integrated positioning, control and data recording; and C-Scan View, a proprietary software to process and represent 2D and 3D maps of the inner surface of the colon.
More about the company
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW